NCLAT lists insolvency appeal filed by Medioint Lifescience's suspended director for hearing on April 28, 2026.
The appellate tribunal orders the continuation of an existing interim order until the next hearing.
The appeal challenges an order from the National Company Law Tribunal involving Almin Extrusion as respondent.